Holly L. Thacker, MD, FACP, NCMP, CCD

Article

Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available

Author:: Anna Camille Moreno, DO; Sabrina K. Sikka, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

Options include locally applied estrogens, DHEA, and estrogen receptor agonists/antagonists.

Article

ERAAs for menopause treatment: Welcome the ‘designer estrogens’

Author:: Heather D. Hirsch, MD, MS, NCMP; Elim Shih, MD, NCMP; Holly L. Thacker, MD, FACP, NCMP, CCD

These drugs stimulate estrogen receptors in some tissues and inhibit them in others, enabling tailored treatment.

Article

Medical management of urinary incontinence in women

Author:: Elim Shih, MD; Heather Hirsch, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

It is common, underreported, and undertreated. Primary care physicians can offer conservative management.

Article

Menopausal hormone therapy

Author:: Holly L. Thacker, MD, FACP, NCMP, CCD

For most women the benefits of menopausal hormone therapy are much greater than the risks.

Article

Sex, statins, and diabetes

Author:: Holly L. Thacker, MD, FACP, NCMP, CCD

Article

Update on contraceptive options: A case-based discussion

Author:: Kristi Tough DeSapri, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

Contraceptive counseling is both an art and a science. Here, the authors present several common scenarios.

Article

Bioidentical hormone therapy: Clarifying the misconceptions

Author:: Lynn Pattimakiel, MD, NCMP; Holly L. Thacker, MD, FACP, NCMP, CCD

Many women are turning to bioidentical hormone therapy on the basis of misconceptions, which we hope to clarify.

Article

Newer hormonal therapies: Lower doses; oral, transdermal, and vaginal formulations

Author:: Mala S. Sivanandy, MD; Nziavake Masimasi, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

We review some of the hormonal regimens that have been approved in the past 5 years.

Article

Update on hormonal contraception

Author:: Nziavake Masimasi, MD; Mala S. Sivanandy, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

The trends are for lower estrogen doses, newer progestins, longer cycles, and non-oral options. A review of the latest products.

Article

Overactive bladder

Author:: Holly L. Thacker, MD, FACP, NCMP, CCD; Marie Paraiso, MD

Article

Treatment options for menopausal hot flashes

Author:: Andrea Sikon, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

Alternatives to hormone therapy exist, but none is as effective as hormone therapy, and none is approved by the US Food and Drug Administration...

Article

Premenstrual dysphoric disorder: A review for the treating practitioner

Author:: Gurjit Kaur, DO; Lilian Gonsalves, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

There are a variety of treatments for this severe form of premenstrual syndrome. Caution is needed with alternative therapies.

Article

The case for hormone replacement: New studies that should inform the debate

Author:: Holly L. Thacker, MD, FACP, NCMP, CCD

Unfortunately, many women who might benefit from hormone replacement may decide to forgo it.

Article

Coronary artery disease in women: Different, often undertreated

Author:: Hani Jneid, MD; Holly L. Thacker, MD, FACP, NCMP, CCD

In coronary artery disease, women are more likely to receive suboptimal and less-aggressive care.

Article

In postmenopausal women who have had a subtotal (simple) hysterectomy, how much estrogen is enough, and how do you test for deficiency?

Author:: Holly L. Thacker, MD, FACP, NCMP, CCD

A standard dosage can be titrated upward according to symptoms.